{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:49:49Z","timestamp":1791946189801,"version":"4.3.4"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Integr. Neurosci."],"DOI":"10.3389\/fnint.2020.00007","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T01:16:52Z","timestamp":1582593412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Metabolic Signatures Differentiate Rett Syndrome From Unaffected Siblings"],"prefix":"10.3389","volume":"14","author":[{"given":"Jeffrey L.","family":"Neul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Annese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heydemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Glaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Percy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1872211308666140602125505","article-title":"Oxidative damage impact on aging and age-related diseases: drug targeting of telomere attrition and dynamic telomerase activity flirting with imidazole-containing dipeptides.","volume":"8","author":"Babizhayev","year":"2014","journal-title":"Recent Pat. Drug. Deliv. Formul."},{"key":"B3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awy323","article-title":"Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder.","volume":"142","author":"Banerjee","year":"2019","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-19-89","article-title":"Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils.","volume":"19","author":"Beloborodova","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1073\/pnas.1603023113","article-title":"Individual variability in human blood metabolites identifies age-related differences.","volume":"113","author":"Chaleckis","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1093\/bioinformatics\/bty528","article-title":"MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data.","volume":"34","author":"Chong","year":"2018","journal-title":"Bioinformatics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.bbagen.2011.12.002","article-title":"Morphological changes and oxidative damage in Rett Syndrome erythrocytes.","volume":"1820","author":"Ciccoli","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J. Med. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/19490976.2015.1035855","article-title":"Autism spectrum disorders and intestinal microbiota.","volume":"6","author":"De Angelis","year":"2015","journal-title":"Gut. Microbes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2009.05.016","article-title":"Systemic oxidative stress in classic Rett syndrome.","volume":"47","author":"De Felice","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2014.04.006","article-title":"Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.","volume":"68","author":"De Felice","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1194\/jlr.P017798","article-title":"F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.","volume":"52","author":"De Felice","year":"2011","journal-title":"J. Lipid. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1749-6632.2012.06611.x","article-title":"The role of oxidative stress in Rett syndrome: an overview.","volume":"1259","author":"De Felice","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009493.pub2","article-title":"N-acetylcarnosine (NAC) drops for age-related cataract.","volume":"2","author":"Dubois","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/088307389901400306","article-title":"Rett syndrome: randomized controlled trial of L-carnitine.","volume":"14","author":"Ellaway","year":"1999","journal-title":"J. Child. Neurol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010883","article-title":"Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.","volume":"5","author":"Gall","year":"2010","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","article-title":"A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.","volume":"76","author":"Glaze","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0883073808327827","article-title":"A study of the treatment of Rett syndrome with folate and betaine.","volume":"24","author":"Glaze","year":"2009","journal-title":"J. Child. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of Neurological Defects in a Mouse Model of Rett Syndrome\u2217.","volume":"8","author":"Guy","year":"2007","journal-title":"Science"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/WNL.42.10.1980","article-title":"Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis.","volume":"42","author":"Hyland","year":"1992","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2217\/14622416.9.4.383","article-title":"Analysis of the adult human plasma metabolome.","volume":"9","author":"Lawton","year":"2008","journal-title":"Pharmacogenomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/17482968.2011.619197","article-title":"Biochemical alterations associated with ALS.","volume":"13","author":"Lawton","year":"2012","journal-title":"Amyotroph. Lateral. Scler"},{"key":"B25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.aca.2008.11.058","article-title":"Comprehensive two-dimensional gas chromatography\/time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus.","volume":"633","author":"Li","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"B26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dyt094","article-title":"Metabolomic markers reveal novel pathways of ageing and early development in human populations.","volume":"42","author":"Menni","year":"2013","journal-title":"Int. J. Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/srep41824","article-title":"Alterations in the carnitine cycle in a mouse model of Rett syndrome.","volume":"7","author":"Mucerino","year":"2017","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neubiorev.2018.12.009","article-title":"Disturbed redox homeostasis and oxidative stress: potential players in the developmental regression in Rett syndrome.","volume":"98","author":"Muller","year":"2019","journal-title":"Neurosci. Biobehav. Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14737159.2016.1202765","article-title":"Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.","volume":"16","author":"Mussap","year":"2016","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"B31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/med\/9780195371826.003.0051","article-title":"Rett Syndrome and MECP2-Related Disorders","author":"Neul","year":"2011","journal-title":"Autism Spectrum Disorders"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature.","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-014-0548-3","article-title":"Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.","volume":"14","author":"Parrinello","year":"2014","journal-title":"Curr. Diab. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1093\/hmg\/ddt111","article-title":"Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.","volume":"22","author":"Pitcher","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1749-6632.1998.tb09920.x","article-title":"Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.","volume":"854","author":"Reiter","year":"1998","journal-title":"Ann. N Y Acad. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/gim.2016.42","article-title":"Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2.","volume":"19","author":"Sajan","year":"2017","journal-title":"Genet. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.","volume":"23","author":"Sas","year":"2018","journal-title":"Molecules"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051586","article-title":"Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.","volume":"7","author":"Schaevitz","year":"2012","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00058","article-title":"Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: implications for Mitochondria-Targeted Therapies.","volume":"11","author":"Shulyakova","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"B42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0387-7604(01)00369-2","article-title":"Oxidative stress in Rett syndrome.","volume":"23","author":"Sierra","year":"2001","journal-title":"Brain Dev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2018.08.016","article-title":"Amino Acid Dysregulation Metabotypes: potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.","volume":"85","author":"Smith","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/bf01799981","article-title":"Urinary D-4-hydroxyphenyllactate, D-phenyllactate and D-2-hydroxyisocaproate, abnormalities of bacterial origin.","volume":"10","author":"Spaapen","year":"1987","journal-title":"J. Inherit. Metab. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/npp.2014.136","article-title":"Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor.","volume":"39","author":"Szczesna","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1212\/WNL.0b013e31826e9a70","article-title":"Growth failure and outcome in Rett syndrome: specific growth references.","volume":"79","author":"Tarquinio","year":"2012","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","article-title":"2-Aminoadipic acid is a biomarker for diabetes risk.","volume":"123","author":"Wang","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0014-2999(95)00224-9","article-title":"L-alpha-aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats.","volume":"281","author":"Wu","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1002\/cpbi.11","article-title":"Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis.","volume":"55","author":"Xia","year":"2016","journal-title":"Curr. Protoc. Bioinformat."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1021\/pr200815c","article-title":"Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging.","volume":"10","author":"Yuan","year":"2011","journal-title":"J. Proteome. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1039\/c1mb05114h","article-title":"C. elegans metallothioneins: response to and defence against ROS toxicity.","volume":"7","author":"Zeitoun-Ghandour","year":"2011","journal-title":"Mol. Biosyst."}],"container-title":["Frontiers in Integrative Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnint.2020.00007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T01:16:59Z","timestamp":1582593419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnint.2020.00007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":52,"alternative-id":["10.3389\/fnint.2020.00007"],"URL":"https:\/\/doi.org\/10.3389\/fnint.2020.00007","relation":{},"ISSN":["1662-5145"],"issn-type":[{"value":"1662-5145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"7"}}